Infectious Risks of Biologic Therapy
Infectious Disease Clinics of North America · 2026-11
DOI: 10.1016/j.idc.2026.10.014 ↗Kurz gefasst
Editorial in der Zeitschrift Infectious Disease Clinics of North America, 2026-11. Verfasst von Jessica Ferguson Toll und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Stanford University, 300 Pasteur Drive Lane L134, MC5107, Stanford, CA 94205, USA. Electroni…. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Stanford University, 300 Pasteur Drive Lane L134, MC5107, Stanford, CA 94205, USA. Electronic address: jferg1@stanford.edu.
- Division of Infectious Diseases, Department of Medicine, Stanford University, 300 Pasteur Drive Lane L134, MC5107, Stanford, CA 94205, USA. Electronic address: asubram2@stanford.edu.
- Division of Infectious Diseases, Department of Medicine, Stanford University, 300 Pasteur Drive Lane L134, MC5107, Stanford, CA 94205, USA. Electronic address: joanna2@stanford.edu.
Zitieren
APA
Ferguson Toll, J., Subramanian, A. K., & Nelson, J. K. (2026). Infectious Risks of Biologic Therapy. Infectious Disease Clinics of North America. https://doi.org/10.1016/j.idc.2026.10.014
Vancouver
Ferguson Toll J, Subramanian AK, Nelson JK. Infectious Risks of Biologic Therapy. Infectious Disease Clinics of North America. 2026. doi:10.1016/j.idc.2026.10.014
BibTeX
@article{FergusonToll2026,
author = {Ferguson Toll, Jessica and Subramanian, Aruna K and Nelson, Joanna K},
title = {Infectious Risks of Biologic Therapy},
journal = {Infectious Disease Clinics of North America},
year = {2026},
doi = {10.1016/j.idc.2026.10.014}
}
EUVIMED